Pentosan Polysulfate Sodium-Associated Pigmentary Retinopathy: Risk Factors and Fundus Findings

References

• Interstitial Cystitis | CDC; 2020. Available from: https://www.cdc.gov/ic/index.html. Accessed November 29, 2020.
   Google Scholar
• Hanno PM, Erickson D, Moldwin R, Faraday MM. American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–1553. doi:10.1016/j.juro.2015.01.086
   PubMed Web of Science ®Google Scholar
• Ortho-McNeil Pharmaceutical. Elmiron-100mg; 2006. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020193s004lbl.pdf. Accessed November 18, 2021.
   Google Scholar
• Humans IWG on the E of CR to. Mechanistic and Other Relevant Data. International Agency for Research on Cancer; 2016. https://www.ncbi.nlm.nih.gov/books/NBK350418/. Accessed December 7, 2020.
   Google Scholar
• Greenlee T, Hom G, Conti T, Babiuch AS, Singh R. Re: pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology. 2019;126(7):e51. doi:10.1016/j.ophtha.2018.12.037
   PubMed Web of Science ®Google Scholar
• Jain N, Li AL, Yu Y, VanderBeek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Br J Ophthalmol. 2020;104(8):1093–1097. doi:10.1136/bjophthalmol-2019-314765
   PubMed Web of Science ®Google Scholar
• Vora RA, Patel AP, Melles R. Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy. Ophthalmology. 2020;127(6):835–836. doi:10.1016/j.ophtha.2020.01.017
   PubMed Web of Science ®Google Scholar
• Pearce WA, Chen R, Jain N. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium. Ophthalmology. 2018;125(11):1793–1802. doi:10.1016/j.ophtha.2018.04.026
   PubMed Web of Science ®Google Scholar
• Hanif AM, Shah R, Yan J, et al. Strength of Association between Pentosan Polysulfate and a Novel Maculopathy. Ophthalmology. 2019;126(10):1464–1466. doi:10.1016/j.ophtha.2019.04.024
   PubMed Web of Science ®Google Scholar
• Barnes AC, Hanif AM, Jain N. Pentosan Polysulfate Maculopathy versus Inherited Macular Dystrophies: comparative Assessment with Multimodal Imaging. Ophthalmol Retina. 2020;4(12):1196–1201. doi:10.1016/j.oret.2020.05.008
   PubMedGoogle Scholar
• Hadad A, Helmy O, Leeman S, Schaal S, Novel Multimethod A. Image Analysis to Quantify Pentosan Polysulfate Sodium Retinal Toxicity. Ophthalmology. 2020;127(3):429–431. doi:10.1016/j.ophtha.2019.10.013
   Web of Science ®Google Scholar
• Lyons RJ, Brower J, Jain N. Visual Function in Pentosan Polysulfate Sodium Maculopathy. Invest Ophthalmol Vis Sci. 2020;61(13):33. doi:10.1167/iovs.61.13.33
   Web of Science ®Google Scholar
• Jain N, Liao A, Garg SJ, et al. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: a Macula Society Collaborative Study. Ophthalmol Retina. 2021. doi:10.1016/j.oret.2021.07.004
   Google Scholar
• Wang D, Velaga SB, Grondin C, et al. Pentosan Polysulfate Maculopathy: prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening. Am J Ophthalmol. 2021;227:125–138. doi:10.1016/j.ajo.2021.02.025
   Web of Science ®Google Scholar
• Dai Y, Jonas JB, Ling Z, Sun X. Ophthalmoscopic-Perspectively Distorted Optic Disc Diameters and Real Disc Diameters. Invest Ophthalmol Vis Sci. 2015;56(12):7076–7083. doi:10.1167/iovs.14-16033
   Web of Science ®Google Scholar
• Ludwig CA, Vail D, Callaway NF, Pasricha MV, Moshfeghi DM. Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States. Ophthalmology. 2020;127(4):535–543. doi:10.1016/j.ophtha.2019.10.036
   Web of Science ®Google Scholar
• VanderBeek BL, Jain N. Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543). Ophthalmology. 2020;127(5):e35–e36. doi:10.1016/j.ophtha.2020.01.004
   Web of Science ®Google Scholar
• Paredes Mogica JA, De EJB. Pentosan Polysulfate Maculopathy: what Urologists Should Know in 2020. Urology. 2020;147:109–118. doi:10.1016/j.urology.2020.08.072
   Web of Science ®Google Scholar
• Uner OE, Shah MK, Jain N. PENTOSAN POLYSULFATE AND VISION: findings from an International Survey of Exposed Individuals. Retina Phila Pa. 2021;41(7):1562–1569. doi:10.1097/IAE.0000000000003078
   Web of Science ®Google Scholar
• De Larochellière E, Bourgault S. Pentosan polysulfate sodium-induced pigmentary maculopathy with non-leaking cystoid macular edema successfully treated with anti-VEGF therapy. Retin Cases Brief Rep. 2020;Publish Ahead of Print. doi:10.1097/ICB.0000000000001013
   Google Scholar
• Hanany M, Rivolta C, Sharon D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases. Proc Natl Acad Sci. 2020;117(5):2710–2716. doi:10.1073/pnas.1913179117
   PubMed Web of Science ®Google Scholar
• Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic Spectrum of Pentosan Polysulfate Sodium–Associated Maculopathy: a Multicenter Study. JAMA Ophthalmol. 2019;137(11):1275–1282. doi:10.1001/jamaophthalmol.2019.3392
   PubMed Web of Science ®Google Scholar
• Barnett JM, Jain N. Potential new onset clinically detectable pentosan polysulfate maculopathy years after drug cessation. Retin Cases Brief Rep. 2020;Publish Ahead of Print. doi:10.1097/ICB.0000000000001090
   Google Scholar
• Shah R, Simonett JM, Lyons RJ, Rao RC, Pennesi ME, Jain N. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation. JAMA Ophthalmol. 2020;138(8):894–900. doi:10.1001/jamaophthalmol.2020.2349
   Web of Science ®Google Scholar
• Quigley HA, Brown AE, Morrison JD, Drance SM. The size and shape of the optic disc in normal human eyes. Arch Ophthalmol Chic. 1990;108(1):51–57. doi:10.1001/archopht.1990.01070030057028
   Google Scholar